PMID: 9175910Jun 1, 1997Paper

Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury

Clinical Immunology and Immunopathology
M NakajimaK Okumura

Abstract

Fas ligand (FasL) is a type II membrane protein which belongs to the tumor necrosis factor family. Ligation of its receptor (Fas/APO-1/CD95) by FasL induces apoptosis of Fas-expressing cells. However, the in vivo function of these molecules in cutaneous immunity is presently unknown. In the present study, we investigated the involvement of Fas and FasL in the pathogenesis of cutaneous lupus by immunohistochemical methods. In normal skin, expression of Fas was observed on keratinocytes in the basal to granular layers. Unexpectedly, FasL was constitutively expressed on histiocytes in the dermis. In specimens of cutaneous lupus, Fas was expressed on infiltrating lymphocytes, as well as on keratinocytes as observed in normal skin. FasL was expressed on a portion of infiltrating CD4+ T cells and on histiocytes more frequently than those in normal skin. Double staining indicated that these FasL-expressing histiocytes were CD68 positive macrophages. Especially, FasL-expressing macrophages were distributed around appendages such as hair follicles. These results suggest the Fas/FasL interaction may be involved in the destruction of hair follicles which is a characteristic feature of cutaneous lupus.

References

Oct 1, 1982·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S M Hsu, E Soban
Dec 1, 1995·The Journal of Experimental Medicine·N KayagakiH Yagita
Nov 17, 1995·Science·T S GriffithT A Ferguson
Mar 1, 1994·The Journal of Clinical Investigation·E MyslerK B Elkon
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·S T JuA Marshak-Rothstein
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·S HanabuchiK Okumura
Sep 1, 1994·The Journal of Investigative Dermatology·K SayamaY Miki
Jan 1, 1995·The Journal of Experimental Medicine·M R AldersonD H Lynch
Feb 2, 1995·Nature·J DheinP H Krammer
Mar 10, 1995·Science·S Nagata, P Golstein
Jan 1, 1995·Immunology Today·S Nagata, T Suda
Oct 19, 1995·Nature·D BellgrauR C Duke
Nov 1, 1995·The Journal of Experimental Medicine·P R GalleL Runkel
Aug 1, 1995·Archives of Dermatology·D A Norris
Aug 26, 1993·Nature·J OgasawaraS Nagata
Mar 10, 1995·Science·H Steller
Aug 1, 1993·The Journal of Investigative Dermatology·A R Haake, R R Polakowska
Dec 1, 1995·Immunology Today·D H LynchM R Alderson
Feb 22, 1996·Nature·H YagitaK Okumura
Oct 1, 1996·The Journal of Experimental Medicine·P DowlingW Husar

❮ Previous
Next ❯

Citations

Nov 5, 1999·The Journal of Pathology·M MüschenD Häussinger
Feb 6, 1999·International Journal of Cancer. Journal International Du Cancer·C MoersD Häussinger
Nov 9, 2000·European Journal of Immunology·T YoshiokaK Okumura
Jan 6, 2010·Rheumatology International·Anna KozłowskaPaweł Piotr Jagodziński
Dec 21, 2007·Clinical Reviews in Allergy & Immunology·Julie H LinVictoria P Werth
Oct 14, 2003·Biochemical Pharmacology·Andreas LinkermannOttmar Janssen
May 16, 2000·The British Journal of Dermatology·T ChristophR Paus
May 22, 2001·The British Journal of Dermatology·B Baima, M Sticherling
Apr 12, 2001·Clinical and Experimental Dermatology·T P Millard, J M McGregor
Jun 17, 1998·The Journal of Clinical Investigation·D H DockrellC V Paya
Aug 27, 2013·Indian Journal of Dermatology, Venereology and Leprology·Sunil Dogra, Rishu Sarangal
Jun 19, 2012·Indian Journal of Dermatology·Moetaz El-DomyatiMahmoud Hamdy
Oct 10, 1998·The British Journal of Dermatology·S H LeeN J Yoo
Nov 22, 2011·The Journal of Dermatology·Manabu Ohyama
Oct 5, 2010·The American Journal of Pathology·Matthew J Harries, Ralf Paus
May 19, 2012·Expert Opinion on Pharmacotherapy·Mariya Miteva, Antonella Tosti
Mar 11, 2005·Expert Opinion on Therapeutic Targets·Andreas LinkermannOttmar Janssen
Mar 31, 2015·Journal of Dermatological Science·Naoko Okiyama, Manabu Fujimoto
May 19, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Craig C HofmeisterJames L M Ferrara
Dec 3, 2014·Cytokine·Anthos ChristofidesChristina Piperi
Aug 2, 2003·Cell Death and Differentiation·O JanssenD Kabelitz
Apr 24, 2017·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Karolina BieńMałgorzata Krzyżowska
Sep 8, 2017·Skin Appendage Disorders·Salvador VillablancaJuan Ferrando
Jul 28, 2020·Frontiers in Immunology·Colton J GarelliJillian M Richmond
Dec 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Begoña SantiagoJosé L Pablos
Apr 21, 2016·The American Journal of Dermatopathology·Charlotte LaSenna, Mariya Miteva
Jun 26, 1998·The Journal of Dermatology·M FushimiM Takigawa
May 28, 2021·Journal of the American Academy of Dermatology·Celina DubinEmma Guttman-Yassky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis